Live Breaking News & Updates on Pembrolizumab Plus Chemotherapy

Stay updated with breaking news from Pembrolizumab plus chemotherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer

Ramez N. Eskander, MD, discusses overall survival data for pembrolizumab plus chemotherapy in advanced/recurrent endometrial cancer.

....

United States , San Diego , Ramezn Eskander , Reproductive Sciences , San Diego Health , University Of California , Moores Cancer Center , Advanced Recurrent Endometrial Cancer , Pembrolizumab Plus Chemotherapy ,

Dr Eskander on Pembrolizumab Plus Paclitaxel and Carboplatin in Endometrial Cancer

Ramez N. Eskander, MD, discusses findings from the phase 3 NRG GY018 trial of pembrolizumab plus chemotherapy in patients with endometrial cancer. ....

Ramezn Eskander , Reproductive Services , Department Of Obstetrics , Division Of Gynecologic Oncology , Gynecologic Oncology , California San Diego Moores Cancer Center , University Of California San Diego Moores Cancer Center , Nrg Gy018 Trial , Pembrolizumab Plus Chemotherapy , Patients With Endometrial Cancer ,